JODIE KAALEKAHI: Open Payments
NPI 1932575883 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 57 payments from 12 companies in 2025. Trend: 2023 $770 · 2024 $1,156 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $244 |
| Janssen Biotech, Inc. | 11 | $214 |
| ABBVIE INC. | 11 | $211 |
| Gilead Sciences, Inc. | 5 | $176 |
| Ipsen Biopharmaceuticals, Inc | 6 | $170 |
| Janssen Scientific Affairs, LLC | 1 | $143 |
| Lilly USA, LLC | 5 | $94 |
| Ardelyx, Inc. | 2 | $57 |
| Napo Pharmaceuticals Inc | 2 | $42 |
| Madrigal Pharmaceuticals | 2 | $38 |
Products named: TREMFYA, ENTYVIO, IQIRVO, OMVOH, MAVYRET, CREON, RINVOQ, IBSRELA.
Industry payments across AZ — which companies pay providers there.
